Can selective Bb inhibition give NovelMed Therapeutics an edge in the multibillion-dollar PNH drug market?
What the Mount Raymond acquisition means for SLAM Exploration Ltd.’s Goodwin project scale (TSXV: SXL)
Read More 2 minute read Pharma Industry News Xencor initiates Phase 1 trial of XmAb20717 for advanced solid tumors Xencor, a prominent biopharmaceutical company based in Monrovia, California, has recently dosed the first patient in a Phase… bypharmanewsdailyJuly 15, 2018
